new weight loss drug glp-1 drugs are about to ship to more American homes GLP-1 Weight-Loss Pills: What You

In the ever-evolving conversation surrounding metabolic health and weight management, glucagon-like peptide-1 (GLP-1) has emerged as a powerful player

adults will qualify as obese by 2030 and nearly 25% as severely obese.i GLP-1s should be a key tool in managing obesity outcomes and costs: Despite higher prescription costs relative to nonusers, persistent GLP-1 use can decrease average annual total cost of care by $14K-$15K (14%) among chronically obese patients in the first one to two years of use

S Korea Prescription Drug Market Size and Forecast, by Type (2025-2032) 7.4.2.2

Notwithstanding, the impact of public health initiatives has been less pronounced in minority groups and persons with mental disorders wherein the rates of smoking remain higher (e.g., 4080% smoking rates amongst persons with depressive, bipolar and psychotic disorders) [29]

Results GLP-1 receptor agonists versus DPP-4 inhibitors The cohort included 36 082 and 234 028 new users of GLP-1 receptor agonists and DPP-4 inhibitors, respectively (fig 1)

[20] Zhang, C., Kaye, J